Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
This Phase 2 study aims to evaluate whether Bruton's tyrosine kinase (BTK) inhibition with remibrutinib can produce a clinically meaningful reduction in inflam…
Papulopustular Rosacea
Estimated
~$10 – $8,750
Novartis PharmaceuticalsNCT07681271
Phase 2
Efficacy and Safety of Topical Clascoterone Cream 1% in Patients With Facial Acneiform Rosacea
To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.
Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea
Estimated
~$10 – $7,500
Narrows Institute for Biomedical ResearchNCT06952517